Omega Healthcare's Q3 earnings boosted by funds available for distribution, reduced leverage
Omega Healthcare Investors reported Q3 earnings with adjusted FFO of $0.82 per share, up from $0.79 a year ago. Revenue increased to $340.55M, but rental income fell. The company raised its 2026 adjusted FFO guidance to $3.28-$3.30. Shares rose 1.01% in post-market trading.
How this was made

The 30-second read
Why it matters
The key tradable catalyst is the raised 2026 adjusted FFO guidance range, supported by Q3 FAD per share outperformance and leverage at the lowest level in the company’s history.
Market read
Guidance raise plus cash-flow metric beats are likely to drive near-term positioning and revisions to 2026 earnings expectations.
What to watch
Traders may focus on the sustainability of rental income weakness and whether accretive investments in late 2026 to early 2027 pressure margins or leverage again.
Background
Omega Healthcare Investors is a healthcare REIT; the article frames Q3 performance around cash-flow metrics (FAD/AFFO) and leverage reduction.
Ticker impact
Omega Healthcare Investors reported Q3 results with funds available for distribution above estimates and raised full-year 2026 adjusted FFO guidance.
Likely upward bias as the market reprices the raised 2026 AFFO range and improved leverage profile.
The article contains a fresh earnings/guidance print with multiple beat metrics (Q3 FAD, adjusted FFO) and an explicit guidance raise for 2026, which typically drives immediate repricing.
Market effects
Reinforces positive read-through for healthcare REITs focused on improving leverage and cash flow metrics (FAD/AFFO).
Limited direct regional spillover; primarily a single-name REIT catalyst.
Low; company-specific earnings and guidance with no stated global macro linkage.
Counterpoint
Revenue growth was mixed, with rental income down versus both prior year and consensus, which could temper enthusiasm despite AFFO/FAD strength.
Key entities
- companyOmega Healthcare Investors
Reported Q3 adjusted FFO and funds available for distribution, reduced leverage, and raised 2026 adjusted FFO guidance.
- personMatthew Gourmand
CEO quoted on Q3 performance, leverage reduction, and expectations for accretive investments.


